University Hospital Zurich
Zurich, 8091, Switzerland
NCT Number: NCT04151771
Peripheral muscle weakness is a predominant problem in patients with COPD and treated using exercise training in pulmonary rehabilitation. Despite pulmonary rehabilitation being an effective intervention, muscle strength impairment is a persisting problem in COPD patients. Patients have problems to tolerate the high training loads, which are necessary to develop strength. Low-load blood flow restriction training (LL-BFRT) might therefore be an option to enhance muscular response of patients with COPD to strength training. Up to now, no studies investigating LL-BFRT in respiratory diseases are available.
The primary outcome of this randomized pilot study is knee extensor muscle strength. Secondary, the study will evaluate if LL-BFRT is well tolerated and feasible in COPD patients attending outpatient pulmonary rehabilitation.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Zurich, 8091, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention group will perform the exercises of the lower limbs using LL-BFRT with an occlusion pressure of 70% of arterial occlusion pressure with low training loads (30% of the 1 repetition maximum).
Other names: LL-BFRT
The control group will perform outpatient pulmonary rehabilitation as established.
Time frame: during 12 weeks (24 exercise sessions)
Between-group difference in total change in isometric muscle strength of the knee extensor muscles, measured by handheld dynamometry in newtonmeter
University of Zurich
Other
Acronym: LL-BFRT COPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06410950
COPD, Chronic Disease
Timișoara, Timiș County, Romania
View Trial DetailsNCT05222295
COPD, Chronic Disease
Istanbul, Zeytinburnu, Turkey (Türkiye)
View Trial DetailsNCT04261452
CHF, COPD
View Trial DetailsNCT01981200
COPD, Chronic Disease
Frederikssund, Denmark
View Trial Details